PTC Therapeutics director Glenn Steele Jr reports sale of 12,000 shares worth $781,920
PTCT•Director Glenn Steele Jr sold 12,000 PTC Therapeutics shares for $781,920 on Sept. 30, 2026, after exercising options for 12,000 shares at $11.23; he directly held 22,500 shares afterward.
1. Share transactions
Glenn Steele Jr. reported selling 12,000 common shares at $65.16 on Sept. 30, 2026, and exercising stock options for 12,000 shares at $11.23 that day. He directly held 22,500 common shares after the transactions.
